FDA Clears Cook’s Vena Cava Filter
July 30, 2007 – The FDA gave Cook Medical, a developer of IVC filters, clearance for a permanent indication for its newest vena cava filter, Celect, which is designed to offer physicians a tool for minimizing the risk of blood clots and pulmonary embolism in their patients.
The Celect filter is an implanted expandable metal device used to capture hazardous blood clots caused by trauma, surgery or other medical conditions before they can reach the lungs, causing a pulmonary embolism. The Celect filter employs a conical shape with a unique strut design that improves centering in the vessel and reduces in-growth except at the desired end points.
The Celect filter is currently cleared for permanent placement in patients in the U.S. In 2006, the Celect filter was approved for permanent and retrieval indications in Canada, Australia and Europe. Trials are currently being conducted with the Celect filter to study other aspects of the device, including retrievability.
Source: Cook Medical
For more information: www.cookmedical.com
More like this
- Cook's Advanced NavAlign Delivery System Adds Speed, Control and Accuracy
- Bioconvertible IVC Filters Could Eliminate Retrieval and Other Complications in Patients
- Femoral Delivery System Aids Vena Cava Filter Placement
- Cook Unveils Integrated Line Peripheral Arterial Disease Devices
- Argon Medical Devices Signs Exclusive Vena Cava Filter Agreement